a significant trendP = 0.0005
Rifampin resistance increased sharply from 37.5% to 100% after 2019, with a significant trend (slope +10.236, P = 0.0005), indicating rapid loss of efficacy.
Rifampin resistance increased sharply from 37.5% to 100% after 2019, with a significant trend (slope +10.236, P = 0.0005), indicating rapid loss of efficacy.
Levofloxacin nonsusceptibility rose from 18.7% (6/32) to 42.3% (11/26) though this overall trend did not reach statistical significance (slope +1.8286, P = 0.0552).